Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Centro Medico Dalinde

Mexico City, Mexico CITY (federal District) 06760, MexicoNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Triple-negative breast cancer

Closed trials

Completed
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
NCT03371017· Phase 3· Hoffmann-La Roche· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Centro Medico Dalinde: trial site – Frontlight Research